Cancer Cell & Molecular Biology Group Media Releases
The following are a list of recent Malaghan Institute media articles related to the research of the Cancer Cell & Molecular Biology Group:
New hope for sufferers of rare lung disease
10 November, 2009
Lymphangioleiomyomatosis or LAM, is a rare but devastating lung disease that most commonly affects women between the ages of 20 and 40. There is currently no cure for LAM, but a new research initiative at the Malaghan Institute of Medical Research, Wellington, funded by the NZ LAM Trust and the LAM Australasia Research Alliance, offers the promise of more effective treatment options for sufferers of this complex disease.
Malaghan Institute joins effort to cure Breast Cancer
10 September, 2009
The Malaghan Institute of Medical Research is to apply its considerable knowledge in developing clinical expertise in cancer immunotherapy to the treatment of breast cancer. This novel therapy uses vaccines to train a patient's immune system to eradicate their cancer and promises to be an invaluable addition to our current breast cancer-fighting arsenal.
Funding for pioneering cancer vaccine research
26 May, 2009
The Malaghan Institute of Medical Research has developed an internationally-recognised cancer immunotherapy research platform that has led to its involvement in clinical trials for non-Hodgkin's lymphoma, metastatic melanoma and glioblastoma. With three new innovative cancer research programmes now underway as a result of recent funding from the Wellington Medical Research Foundation Inc (WMRF), the Institute is a step closer towards its goal of providing cancer sufferers with more effective non-invasive ways of treating their disease.
Scratching the surface of cancer drug targets
24 October, 2008
For over 50 years the focus of most anticancer drug development has been on rapidly dividing cancer cells. These drugs typically act inside the cancer cell to block cogs in the machinery that controls cell growth and division. However, drug resistance, unpalatable side effects and the re-emergence of cancers following drug withdrawal remain major obstacles that need to be overcome if we are to cure cancer.
International Award for Anti-Inflammatory Research
14 August, 2008
In recognition of their cutting-edge research into the discovery of novel anti-inflammatory compounds from New Zealand's natural resources, the international Arthur E Schwarting Award for best paper published in the Journal of Natural Products in 2007 has been awarded to New Zealand researchers from The University of Auckland, the Malaghan Institute of Medical Research, Crop & Food Research and the National Institute of Water and Atmospheric Research (NIWA).
Targeting Melanoma at its source
08 August, 2008
A team of cancer researchers at the Malaghan Institute of Medical Research in Wellington has teamed up with scientists at the Ludwig Institute in Melbourne, to develop novel treatments for melanoma.
Radio NZ Cancer Research Interview
04 August, 2008
The latest Malaghan Institute researcher to feature on the Radio NZ programme "Our Changing World" is Dr Melanie McConnell. Click on the link below to hear her speak about her very interesting research into cancer stem cells.
Malaghan hosting Mayo Clinic Symposium
10 January, 2007
From Sunday 14 January to Thursday 18 January the 4th Mayo Clinic State of the Art Symposium on Haematologic Malignancies will be held at Wellington's Michael Fowler Centre. This will be followed on Friday 19 January by a Malaghan Institute of Medical Research Mini-symposium on Cancer Stem Cells and Cell Therapies.
